SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-23-032018
Filing Date
2023-04-24
Accepted
2023-04-24 16:10:16
Documents
14
Period of Report
2023-04-24
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea177340-8k_orionbiotech.htm   iXBRL 8-K 44944
2 PRESS RELEASE, DATED APRIL 24, 2023 ea177340ex99-1_orionbiotech.htm EX-99.1 8643
  Complete submission text file 0001213900-23-032018.txt   286646

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE oria-20230424.xsd EX-101.SCH 4177
4 XBRL DEFINITION FILE oria-20230424_def.xml EX-101.DEF 27421
5 XBRL LABEL FILE oria-20230424_lab.xml EX-101.LAB 38178
6 XBRL PRESENTATION FILE oria-20230424_pre.xml EX-101.PRE 26041
8 EXTRACTED XBRL INSTANCE DOCUMENT ea177340-8k_orionbiotech_htm.xml XML 7484
Mailing Address ONE VANDERBILT AVENUE, 26TH FLOOR NEW YORK NY 10017
Business Address ONE VANDERBILT AVENUE, 26TH FLOOR NEW YORK NY 10017 212-303-7822
Orion Biotech Opportunities Corp. (Filer) CIK: 0001847416 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40410 | Film No.: 23840190
SIC: 6770 Blank Checks